Erratum: Author correction to "Immune-awakening -inspired nanocarrier for oral target delivery to lymph and tumors" [Acta Pharmaceutica Sinica B 12 (2022) 4501-4518].

Acta Pharm Sin B

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, China.

Published: March 2024

The text indicates that there is a correction made to a specific article, identified by its DOI number (10.1016/j.apsb.2022.04.018).
The correction likely addresses errors or inaccuracies found in the original publication.
This implies the importance of maintaining accurate scientific literature for the benefit of the research community.

[This corrects the article DOI: 10.1016/j.apsb.2022.04.018.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10934333	PMC
http://dx.doi.org/10.1016/j.apsb.2023.08.005	DOI Listing

Publication Analysis

erratum author

author correction

correction "immune-awakening

"immune-awakening -inspired

-inspired nanocarrier

nanocarrier oral

oral target

target delivery

delivery lymph

lymph tumors"

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!